Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy. Urtė holds an MA in International Journalism from City, University of London.
The company plans to conduct several trials with its drug-device combo in schizophrenia and opioid use disorder over the next couple of years.
At the FT Global Pharma and Biotech Summit in London, various industry players shared their thoughts on technological and regulatory advancements.
The early feasibility study will investigate the safety of BCI device implantation and its efficacy for daily digital tasks in patients with paralysis.
Even though telemedicine is the most used DCT component, it lacks a personal touch and ability to represent all skin tones in dermatology clinical trials.
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
Give your business an edge with our leading industry insights.